Tecson, Maylyn B.

HRN: 11-67-82  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2022
CEFUROXIME 500MG (TAB)
06/10/2022
06/17/2022
PO
500mg
Q12H
UTI
Waiting Final Action 
03/14/2023
CEFUROXIME 1.5GM (VIAL)
03/14/2023
03/14/2023
IV
1.5gram
1 Doses
Prophylaxis
Waiting Final Action 
03/14/2023
CEFUROXIME 1.5GM (VIAL)
03/14/2023
03/16/2023
IV
1.5g
Q8hr X 3 Doses
S/P LTCS With IUD Insertion
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: